Unknown

Dataset Information

0

Vigorous, regular physical exercise may slow disease progression in Alzheimer's disease.


ABSTRACT:

Introduction

Mild to moderate exercise may decrease Alzheimer's disease (AD) risk, but the effects of vigorous, regular physical exercise remain unclear.

Methods

Two patients with initial diagnoses of amnestic mild cognitive impairment (MCI) demonstrated positive AD biomarkers throughout 16 and 8 years of follow-up, with final diagnoses of mild AD and amnestic MCI, respectively.

Results

Patient 1 was diagnosed with amnestic MCI at age 64. Neuropsychological testing, magnetic resonance imaging (MRI), fluorodeoxyglucose-positron emission tomography (FDG-PET), amyloid imaging PET, and cerebrospinal fluid (CSF) biomarkers during follow-ups remained consistent with AD. By age 80, progression was minimal with Montreal Cognitive Assessment (MoCA) 26 of 30. Patient 2 was diagnosed with amnestic MCI at age 72. Neuropsychological testing, MRI, FDG-PET, and amyloid imaging PET during follow-ups remained consistent with AD. At age 80, MoCA was 27 of 30 with no clinical progression. Both patients regularly performed vigorous, regular exercise that increased after retirement/work reduction.

Discussion

Vigorous, regular exercise may slow disease progression in biomarker-positive amnestic MCI and mild AD.

SUBMITTER: Devanand DP 

PROVIDER: S-EPMC10101862 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vigorous, regular physical exercise may slow disease progression in Alzheimer's disease.

Devanand Davangere P DP   Masurkar Arjun V AV   Wisniewski Thomas T  

Alzheimer's & dementia : the journal of the Alzheimer's Association 20230201 4


<h4>Introduction</h4>Mild to moderate exercise may decrease Alzheimer's disease (AD) risk, but the effects of vigorous, regular physical exercise remain unclear.<h4>Methods</h4>Two patients with initial diagnoses of amnestic mild cognitive impairment (MCI) demonstrated positive AD biomarkers throughout 16 and 8 years of follow-up, with final diagnoses of mild AD and amnestic MCI, respectively.<h4>Results</h4>Patient 1 was diagnosed with amnestic MCI at age 64. Neuropsychological testing, magneti  ...[more]

Similar Datasets

| S-EPMC1336790 | biostudies-literature
| S-EPMC8883509 | biostudies-literature
| S-EPMC9158463 | biostudies-literature
| S-EPMC3136051 | biostudies-literature
| S-EPMC6129739 | biostudies-literature
| S-EPMC12147321 | biostudies-literature